Navigation Links
InteKrin Therapeutics Presented Phase 2b Clinical Data at the 2010 American Diabetes Association Annual Meeting, Demonstrating Improved Glycemic Control in Patients with Type 2 Diabetes Without Causing the Edema Seen with Pioglitazone
Date:6/29/2010

LOS ALTOS, Calif., June 29 /PRNewswire/ -- InteKrin Therapeutics presented 6 month Phase 2b clinical data for edema in diabetic patients showing differentiation for INT131, a Selective PPAR-gamma Modulator (SPPARM), from Actos® (pioglitazone), yesterday at the American Diabetes Association annual meeting in Orlando, FL.

INT131 besylate (INT131) is a novel, non-TZD, selective oral PPAR-gamma modulator (SPPARM) designed to improve glucose metabolism while minimizing the side effects of the TZD full PPAR-gamma agonists such as Actos®: fluid retention (edema), CHF, bone fracture, and weight gain. The Phase 2b trial, INT131-007, was a 366 patient 24 wk double blind study comparing 4 doses of INT131 to maximal dose Actos® (pioglitazone) or placebo in patients with poorly controlled T2DM on stable dose sulfonylurea (SU) with or without metformin (met). Lower extremity edema was assessed with a predefined scoring tool designed for maximal sensitivity for pitting edema at baseline, 12, and 24 wks. Results show INT131 improved glycemic control as measured by HbA1c comparable to Actos® but without evidence of any significant change in edema compared to baseline or placebo. Substantial edema was noted in the pioglitazone group, consistent with published data. These findings support the SPPARM function of INT131 and suggest it represents a safer insulin sensitizer.

"This data clearly differentiates INT131 besylate from pioglitazone with respect to the important clinical parameter of edema," remarked Dr. Alex DePaoli, Acting Chief Medical Officer of InteKrin Therapeutics, who presented the data. "These findings are consistent with previous clinical data and support the advantages of the SPPARM nature of this agent."

"Insulin
'/>"/>

SOURCE InteKrin Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131
2. InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study
3. InteKrin Therapeutics to Present at the 2009 American Diabetes Association Annual Meeting
4. InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study of Diabetes Meeting
5. InteKrin Therapeutics Co-Founder Receives Appointment as Professor of Medicine at Harvard Medical School
6. InteKrin Therapeutics to Present Phase 2b Clinical Data for Edema at the 2010 American Diabetes Association Annual Meeting
7. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
8. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
11. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/32cmct/inferior_vena ... Vena Cava (IVC) Filters - Global Trends, Estimates and ... http://photos.prnewswire.com/prnh/20130307/600769 Global Inferior ... US$435 million by 2016. The North America ... global value while Europe claims ...
(Date:12/15/2014)... BERGEN, Norway , December 15, 2014 ... developing innovative drugs for aggressive drug resistant cancers, today ... million) in a private placing from new and existing ... the financing to support the development of its pipeline ... development program for its lead drug candidate, BGB324, a ...
(Date:12/15/2014)... PLYMOUTH MEETING, Pa. , Dec. 15, 2014 ... ) announced today it has been added to ... the NASDAQ Biotechnology Index will become effective upon ... The NASDAQ Biotechnology Index is designed to track ... that are classified as either biotechnology or pharmaceutical ...
Breaking Medicine Technology:Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 2Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 3Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 4BerGenBio Completes NOK90 Million Fundraising 2Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 2Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 3Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 4
... MELVILLE, N.Y., May 7, 2012 Henry Schein, Inc., (NASDAQ: ... products and services to office-based dental, medical and animal health ... Executive Vice President and Chief Financial Officer, will present at ... on May 9, 2012.  The conference is being held at ...
... MARLBOROUGH, Mass., May 7, 2012  CardioFocus, Inc., developer ... the treatment of atrial fibrillation (AF), announces that ... of the scientific sessions and during a private ... Rhythm Society,s 33rd Annual Scientific Sessions, May 9-12 ...
Cached Medicine Technology:Henry Schein To Present At The Deutsche Bank 37th Annual Health Care Conference 2Worldwide Multicenter Experiences with CardioFocus HeartLight® EAS to be Presented at Heart Rhythm 2012 2Worldwide Multicenter Experiences with CardioFocus HeartLight® EAS to be Presented at Heart Rhythm 2012 3
(Date:12/19/2014)... 2014 Hands On Mobile Spa, has announced ... Spa On Wheels has been transformed into a utopia for ... world seems to disappear. The Virtual Tour showcases the beauty ... parties, corporate events and more. , The Virtual Tour shows ... which is actually an overhauled Winnebago. Marla Kaplan-Pelle, Director states ...
(Date:12/19/2014)... 19, 2014 Slone Partners ... personalized medicine, healthcare information technology, and laboratory testing ... of Chief Operating Officer. The announcement comes after ... by a strengthened presence in Boston and several ... lives and breathes the client experience," said Adam ...
(Date:12/19/2014)... Wilmington, VT (PRWEB) December 19, 2014 ... full-service private ski club in Southern Vermont’s Deerfield Valley, ... trail names inspired by classic rock songs. , ... the weekend with a private concert followed by a ... said, “The new trail names include: “I’m Alright” the ...
(Date:12/19/2014)... Amy Norton HealthDay Reporter ... to moms who were exposed to high levels of air ... developing autism, a U.S. study suggests. Researchers found that ... and 2002, those exposed to the most air pollution during ... later developed autism. And exposure during the third trimester, specifically, ...
(Date:12/19/2014)... HealthDay Reporter THURSDAY, Dec. 18, ... leg for at least 20 seconds you may be at ... on one leg may indicate that small strokes or tiny ... serious strokes is high, the investigators reported online Dec. 18 ... while standing on one leg, as well as problems walking, ...
Breaking Medicine News(10 mins):Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 2Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 3Health News:Slone Partners Promotes Leslie Loveless to Chief Operating Officer 2Health News:The Hermitage Club Officially Names Four Ski Trails after Iconic Rock Songs by Grammy Award Winner Kenny Loggins 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 3Health News:Can You Balance on One Leg? You May Have Lower Stroke Risk 2
... , THURSDAY, May 3 (HealthDay News) -- New ... a significant role in a major advance in human brain ... SRGAP2 gene has been duplicated at least twice during human ... 2.5 million years ago. The second duplication produced only a ...
... Being cut off from work email significantly reduces stress and ... study by UC Irvine and U.S. Army researchers. Heart ... office setting, while software sensors detected how often they switched ... and were in a steady "high alert" state, with more ...
... Brophy Marcus HealthDay Reporter , THURSDAY, May ... to plague people with celiac disease than those without ... the digestive tract and the brain has been studied ... researchers have linked celiac disease and other bowel problems ...
... health research programs are collaborating with community groups to ... informed consent, collect data and provide input on study ... researchers, community groups and institutional review boards about research ... that have a role in community-engaged research," according to ...
... News) -- Despite the fact that Americans spend more on ... a new report finds that more does not necessarily equal ... Commonwealth Fund report, led by senior research associate David Squires, ... per capita for health care, according to 2009 figures. By ...
... protein complex involved in the spatial organization of the ... have two versions of cohesin that contain either SA1 ... ignored. Researchers of the Spanish National Cancer Research Centre ... new functions of cohesin SA1 that are relevant for ...
Cached Medicine News:Health News:New Clues to the Evolution of the Human Brain 2Health News:Email 'vacations' decrease stress, increase concentration, researchers say 2Health News:Migraines More Likely for People With Celiac Disease, Study Says 2Health News:Migraines More Likely for People With Celiac Disease, Study Says 3Health News:Better ethics education needed in community-based research 2Health News:U.S. Health Care Spending High, But Quality Lags: Report 2Health News:U.S. Health Care Spending High, But Quality Lags: Report 3Health News:CNIO researchers describe new functions of cohesin relevant for human disease 2
It provides excellent illumination from an inexpensive platform and is mounted on the comfortable UltraLite headband....
The ICP-Monitor for intraventricular, intraparenchymal and epidural measurement of intracranial pressure and for measuring cerebral perfusion pressure and compliance....
... The CODMAN ICP ... accurate measurements of intracranial ... parenchymal or intraventricular levels. ... electronically rather than through ...
The Optical Tracking System provides a complete solution for image-guided surgery. Precision tracking technology converges with powerful visualization software for optimal surgical planning and navig...
Medicine Products: